Neurocentria
Phase 220 years of studying regulation of synaptic density and function led us to identify intracellular magnesium as a critical second messenger controlling synaptic function and plasticity.
Founded
2012
Focus
Small Molecules
About
20 years of studying regulation of synaptic density and function led us to identify intracellular magnesium as a critical second messenger controlling synaptic function and plasticity.
Funding History
2Total raised: $1.7M
Grant$500KNIH SBIRMay 15, 2019
Seed$1.2MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2012
LocationSan Francisco, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile